Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
12 12 2019
Historique:
received: 21 08 2019
accepted: 07 12 2019
entrez: 14 12 2019
pubmed: 14 12 2019
medline: 12 6 2020
Statut: epublish

Résumé

High-fat diets increase risk for Alzheimer's disease, but individuals with the risk gene APOE ε4 (E4) paradoxically have improved memory soon after high fat feeding. Little is known about how dietary lipids affect CNS lipids, especially in older adults. We analyzed the lipidomic signature of cerebrospinal fluid (CSF) in older adults who underwent both a saline and TG infusion. We further analyzed these data by E4 carrier status. Older adults (n = 21, age 67.7 ± 8.6) underwent a 5-h TG and saline infusion on different days in random crossover design; lumbar CSF was collected at the end of the infusion. Lipids were extracted using dichloromethane/methanol and 13 classes of lipids analyzed using the Lipidyzer platform consisting of an AB Sciex 5500 MS/MS QTraps system equipped with a SelexION for differential mobility spectrometry (DMS). Multiple reaction monitoring was used to target and quantify 1070 lipids in positive and negative ionization modes with and without DMS. The TG infusion increased total lipids in the CSF, including the appearance of more lipids at the detection limit in the TG samples compared to saline (Chi square p < 0.0001). The infusion increased the total level of diacylglycerols and lysophosphatidylcholines and reduced dihydroceramides. Of the possible 1070 lipids detectable, we found 348 after saline and 365 after TG infusion. Analysis using MetaboAnalyst revealed 11 specific lipids that changed; five of these lipids decreased after TG infusion, and four of them differed by E4 status, but none differed by cognitive diagnosis or sex. These results in older adults show that blood lipids affect lipid profiles in CSF and such profiles are modified by APOE status. This suggests that how the CNS handles lipids may be important in the AD phenotype.

Identifiants

pubmed: 31832778
doi: 10.1007/s11306-019-1627-x
pii: 10.1007/s11306-019-1627-x
pmc: PMC7147960
mid: NIHMS1564016
doi:

Substances chimiques

Apolipoproteins E 0
Biomarkers 0
Lipids 0
Triglycerides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Subventions

Organisme : NIH HHS
ID : S10 OD021562
Pays : United States
Organisme : NIH HHS
ID : 1S10OD021562-01
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG049638
Pays : United States
Organisme : NIA NIH HHS
ID : L30 AG043135
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG047978
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK017047
Pays : United States

Références

JAMA. 1997 Oct 22-29;278(16):1349-56
pubmed: 9343467
Neurosci Lett. 2012 May 16;516(2):302-5
pubmed: 22521584
Biol Pharm Bull. 2017;40(8):1161-1164
pubmed: 28768997
J Neural Transm (Vienna). 2003 Aug;110(8):949-55
pubmed: 12898349
J Nucl Med. 1995 Dec;36(12):2261-7
pubmed: 8523117
PLoS One. 2012;7(7):e41503
pubmed: 22911803
Neurosci Lett. 1993 Feb 5;150(1):17-20
pubmed: 8469396
J Mol Neurosci. 2007 Sep;33(1):12-7
pubmed: 17901540
J Lipid Res. 1990 Mar;31(3):545-8
pubmed: 2341813
Curr Alzheimer Res. 2011 Aug;8(5):479-91
pubmed: 21605054
J Alzheimers Dis. 2015;48(1):205-18
pubmed: 26401941
Expert Rev Neurother. 2011 May;11(5):677-708
pubmed: 21539488
J Neuroimmune Pharmacol. 2013 Dec;8(5):1136-46
pubmed: 24203462
Microvasc Res. 1997 Mar;53(2):163-6
pubmed: 9143548
Biochim Biophys Acta. 2012 Sep;1822(9):1442-52
pubmed: 22627108
Br J Nutr. 2009 Oct;102(8):1121-4
pubmed: 19828088
Prog Lipid Res. 2011 Oct;50(4):313-30
pubmed: 21703303
J Lipid Res. 2013 Oct;54(10):2884-97
pubmed: 23868911
Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):85-91
pubmed: 18938067
Neurobiol Aging. 2014 Oct;35(10):2369-81
pubmed: 24684787
J Neurosci. 2003 Jul 2;23(13):5928-35
pubmed: 12843297
Int J Environ Res Public Health. 2009 Apr;6(4):1335-40
pubmed: 19440521
Alzheimers Res Ther. 2012 Feb 01;4(1):5
pubmed: 22293144
J Mol Neurosci. 2001 Apr-Jun;16(2-3):181-93; discussion 215-21
pubmed: 11478373
Adv Biol Regul. 2014 Jan;54:12-23
pubmed: 24076015
Int J Obes (Lond). 2018 Mar;42(3):391-397
pubmed: 28990588
J Lipid Res. 2017 Nov;58(11):2083-2101
pubmed: 28528321
Bioanalysis. 2014 Feb;6(4):541-61
pubmed: 24568356
Neurology. 2005 Nov 8;65(9):1409-14
pubmed: 16275829
Cell Stem Cell. 2019 Mar 7;24(3):363-375.e9
pubmed: 30686764
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Front Physiol. 2012 Sep 28;3:385
pubmed: 23060810
Neurology. 2013 Apr 30;80(18):1684-92
pubmed: 23628929
Sci Rep. 2017 Mar 08;7:43701
pubmed: 28272510
Biofactors. 2009 May-Jun;35(3):239-48
pubmed: 19472365
Diabetes. 2013 Mar;62(3):783-8
pubmed: 23274886
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Nat Commun. 2017 Nov 13;8(1):1464
pubmed: 29133888
J Neurochem. 2011 Aug;118(4):611-5
pubmed: 21682722
PLoS One. 2014 Jun 23;9(6):e100519
pubmed: 24956173
J Lipid Res. 1992 Apr;33(4):447-54
pubmed: 1388198
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1318-25
pubmed: 23670794
JAMA. 2010 Nov 3;304(17):1903-11
pubmed: 21045096
Sci Rep. 2017 Dec 15;7(1):17652
pubmed: 29247199
J Neurotrauma. 2016 Jul 15;33(14):1331-48
pubmed: 26714394
Transl Psychiatry. 2012 Oct 02;2:e164
pubmed: 23032941
JAMA Neurol. 2013 Aug;70(8):972-80
pubmed: 23779114
Metabolomics. 2016;12:91
pubmed: 27110228
J Cell Mol Med. 2008 Dec;12(6B):2762-71
pubmed: 18318693
Neurology. 2013 Oct 22;81(17):1492-9
pubmed: 24027056
PLoS One. 2011;6(10):e24777
pubmed: 22046234
J Proteome Res. 2016 Feb 5;15(2):608-18
pubmed: 26717242
Adv Biol Regul. 2018 Jan;67:101-108
pubmed: 28918129
Brain. 2014 Aug;137(Pt 8):2271-86
pubmed: 24893707
Physiol Behav. 1986;36(6):1161-5
pubmed: 3725921

Auteurs

Angela J Hanson (AJ)

Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, USA. hansonaj@uw.edu.

William A Banks (WA)

Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.

Lisa F Bettcher (LF)

Department of Anesthesiology and Pain Medicine, Northwest Metabolomics Research Center, University of Washington, Seattle, WA, USA.

Robert Pepin (R)

Department of Anesthesiology and Pain Medicine, Northwest Metabolomics Research Center, University of Washington, Seattle, WA, USA.

Daniel Raftery (D)

Department of Anesthesiology and Pain Medicine, Northwest Metabolomics Research Center, University of Washington, Seattle, WA, USA.

Suzanne Craft (S)

Wake Forest School of Medicine, Department of Internal Medicine, Winston-Salem, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH